Citation Impact
Citing Papers
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
2008 Standout
Significance of Periprocedural Myonecrosis on Outcomes After Percutaneous Coronary Intervention
2008
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Development and feasibility testing of decision support for patients who are candidates for a prophylactic implantable defibrillator: a study protocol for a pilot randomized controlled trial
2013
Rationale and design of the valsartan heart failure trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure
1999
Universal Definition of Myocardial Infarction
2007 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both
2003 Standout
The Failing Heart — An Engine Out of Fuel
2007 Standout
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>
2003 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
Percutaneous Repair or Surgery for Mitral Regurgitation
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
Antagonists of Aldosterone and Proteinuria in Patients With CKD: An Uncontrolled Pilot Study
2005
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Choosing treatment and screening options congruent with values: Do decision aids help? Sub-analysis of a systematic review
2015
Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition
2009
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
2003 Standout
Chronic kidney disease
2011 Standout
Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality
2006
A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure
2001 Standout
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Clinically Relevant Outcomes Based on Analysis of Pooled Data from 2 Trials of Duloxetine in Patients with Knee Osteoarthritis
2011
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
2003 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design
1999
Myocarditis
2011 Standout
Interventions for improving the adoption of shared decision making by healthcare professionals
2010
Growth Differentiation Factor 11 Is a Circulating Factor that Reverses Age-Related Cardiac Hypertrophy
2013 Standout
Safety and Tolerability of Angiotensin-Converting Enzyme Inhibitor Versus the Combination of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker in Patients With Left Ventricular Dysfunction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2008
Guidelines for Percutaneous Coronary Interventions
2005
Drugs targeting the renin–angiotensin–aldosterone system
2002
From the hope to the ontarget and the transcend studies: challenges in improving prognosis
2002
Heart failure
2005
Peri-procedural myocardial injury: 2005 update
2005
OARSI recommendations for the management of hip and knee osteoarthritis
2010
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
2014 Standout
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation
2007 Standout
Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
2006 Standout
Transition‐Metal‐Catalyzed Direct Arylation of (Hetero)Arenes by CH Bond Cleavage
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors
2006 StandoutNobel
Myocarditis
2009 Standout
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
2010 Standout
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Baseline demographics of the Valsartan Heart Failure Trial
2000
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Evaluating Quality of Care for Patients With Heart Failure
2000
Diagnosis and Treatment of Hip and Knee Osteoarthritis
2021 Standout
Efficacy and Safety of Exercise Training in Patients With Chronic Heart Failure
2009 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Decision aids for people facing health treatment or screening decisions
2017 Standout
Dual Blockade of the Renin-Angiotensin System for Cardiorenal Protection: An Update
2009
Forecasting the Future of Cardiovascular Disease in the United States
2011 Standout
Interventions for improving the adoption of shared decision making by healthcare professionals
2014
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist Device
2009 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults
2013 Standout
Viscosupplementation for the treatment of osteoarthritis of the knee
2006
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Shared Decision Making — The Pinnacle of Patient-Centered Care
2012 Standout
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Works of Dan Pericak being referenced
The effectiveness of hylan G-F 20 in patients with knee osteoarthritis: an application of two sets of response criteria developed by the OARSI and one set developed by OMERACT–OARSI
2005
Evaluation of WOMAC 20, 50, 70 response criteria in patients treated with hylan G-F 20 for knee osteoarthritis
2004
Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis
2004
Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
2006
Radial Artery Versus Femoral Artery Access Options in Coronary Angiogram Procedures
2012
Incidence, predictors, and clinical significance of troponin-I elevation without creatine kinase elevation following percutaneous coronary interventions
2004
Comparison of Candesartan, Enalapril, and Their Combination in Congestive Heart Failure
1999